Results 201 to 210 of about 3,050,618 (255)

Programmable ZBTB7A RNA N⁶-methyladenosine site-specific demethylation suppresses colorectal cancer liver metastasis. [PDF]

Mol Cancer
Chen X, Zhao S, Liu B, Fan Y, Qiu H, Ren L, Zhang X, Yan S, An Y, Li S, An J, Wang J, Hu H.   +12 more
europepmc   +1 more source

Epigenetic Silencing of miR-124 Drives KITENIN Activation in Colorectal Cancer. [PDF]

Biomol Ther (Seoul)
Park SY, Varlı M, Kim H.
europepmc   +1 more source

p53 and p21 Status Influences Cellular Response to Metformin in <i>KRAS</i>-Mutant HCT116 Colorectal Cancer Cells. [PDF]

Curr Issues Mol Biol
Saeed A, Hijazi J, Bashir Z, Khoueiry P, Eid AA, Darwiche N, Bengoechea-Alonso MT, Ericsson J, Mifsud BI, Nemer G.   +9 more
europepmc   +1 more source

Overcoming Resistance: Targeting Survivin-Driven Apoptotic Resistance Restores Irinotecan Sensitivity in <i>TP53</i>-Mutant Colorectal Cancer. [PDF]

Cancers (Basel)
Dumut DC, Xu YZ, Verelli D, Das V, Hajduch M, De Sanctis JB, Radzioch D.   +6 more
europepmc   +1 more source

Aryl hydrocarbon receptor promotes the proliferation and aggressive progression of colorectal cancer under high-fat diet via activating INPP4B/AKT/SGK3 signaling pathway. [PDF]

Front Oncol
Dong Q, Wu T, Yang Y, Yang Y, Gao B, Shi D, Wang H, Yan Y.   +7 more
europepmc   +1 more source

Active ingredients and molecular targets of Tripterygium wilfordii against colorectal cancer: network pharmacology, molecular docking, molecular dynamics simulations and in vitro evaluation. [PDF]

J Comput Aided Mol Des
Gu Q, Zhao S, Zhang X, Zhou L, Wu X, Bian W, Zhu C, Tan G.   +7 more
europepmc   +1 more source

Evaluating KRAS-Associated Responses to Sulfasalazine and 5-Fluorouracil in Colorectal Cancer Using Integrated 2D and PEGDA Microwell-Based 3D Tumor Models. [PDF]

Int J Mol Sci
Bandegi M, Biltekin E, Akay YM, Akay M.
europepmc   +1 more source

[Retracted] Restoration of the tumor‑suppressor function to mutant p53 by <i>Ganoderma lucidum</i> polysaccharides in colorectal cancer cells. [PDF]

Oncol Rep
Jiang D, Wang L, Zhao T, Zhang Z, Zhang R, Jin J, Cai Y, Wang F.   +7 more
europepmc   +1 more source

Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich. [PDF]

J Exp Clin Cancer Res
Pennel KAF, Hatthakarnkul P, Wood CS, Lian GY, Al-Badran SSF, Quinn JA, Legrini A, Inthagard J, Alexander PG, van Wyk H, Kurniawan A, Hashmi U, Gillespie MA, Mills M, Ammar A, Hay J, Andersen D, Nixon C, Rebus S, Chang DK, Kelly C, Harkin A, Graham J, Church D, Tomlinson I, Saunders M, Iveson T, Lannagan TRM, Jackstadt R, Maka N, Horgan PG, Roxburgh CSD, Sansom OJ, McMillan DC, Steele CW, Jamieson NB, Park JH, Roseweir AK, Edwards J.   +38 more
europepmc   +1 more source

Acetyltransferase NAT10 promotes aggressiveness of colorectal cancer cells via ac⁴C acetylation of SERPINA1 mRNA. [PDF]

BMC Cancer
Fan W, Ma X.
europepmc   +1 more source